Manufacturer:
Bristol Myers Squibb
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults
- treatment of moderately-to-severely active ulcerative colitis in adults
Conditions:
- Multiple Sclerosis
- Ulcerative Colitis
Therapeutic Area:
- Gastroenterology
- Neurology